Long-term survival of patients with metastatic melanoma (MM) treated with dacarbazine (DTIC) or temozolomide (TMZ)

被引:0
|
作者
Kim, C.
Lee, C. W.
Klasa, R.
Shah, A.
Savage, K. J.
机构
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9054
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma
    Bedikian, Agop Y.
    Johnson, Marcella M.
    Warneke, Carla L.
    Papadopoulos, Nicholas E.
    Kim, Kevin
    Hwu, Wen-Jen
    Mclntyre, Susan
    Hwu, Patrick
    CANCER INVESTIGATION, 2008, 26 (06) : 624 - 633
  • [32] A phase II randomized study of ramucirumab (IMC-1121B) with or without dacarbazine (DTIC) in patients (pts) with metastatic melanoma (MM)
    Carvajal, R. D.
    Wong, M. K.
    Thompson, J. A.
    Gordon, M. S.
    Lewis, K. D.
    Pavlick, A. C.
    Wolchok, J. D.
    Fox, F. E.
    Schwartz, J. D.
    Badikian, A. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Prognostic Factors in a Cohort of Dacarbazine Treated Patients for Metastatic Melanoma
    Bexiga, J. Godinho
    Carneiro, F.
    Sousa, N.
    Ferreira, P.
    Raimundo, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S658 - S658
  • [34] LONG-TERM SURVIVAL OF PATIENTS WITH ADVANCED MELANOMA TREATED SECOND LINE WITH IPILIMUMAB
    Lee, D.
    Pericleous, L.
    Lebmeier, M.
    Winn, B.
    Batty, A.
    Nikoglou, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 370 - 370
  • [35] Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
    Sacco, Joseph J.
    Carvajal, Richard D.
    Butler, Marcus O.
    Shoushtari, Alexander N.
    Hassel, Jessica C.
    Ikeguchi, Alexandra
    Hernandez-Aya, Leonel
    Nathan, Paul
    Hamid, Omid
    Piulats, Josep M.
    Rioth, Matthew
    Johnson, Douglas B.
    Luke, Jason J.
    Espinosa, Enrique
    Leyvraz, Serge
    Collins, Laura
    Holland, Chris
    Sato, Takami
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (06)
  • [36] Long-Term Survival in Patients With Advanced Melanoma
    van Not, Olivier J.
    van den Eertwegh, Alfons J. M.
    Jalving, Hilde
    Bloem, Manja
    Haanen, John B.
    van Rijn, Rozemarijn S.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot J. W. B., Jan Willem
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Leeneman, Brenda
    Piersma, D.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil G., Gerard
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [37] Immunomodulation of pembrolizumab (pembro) treated metastatic melanoma patients (pts) after progression with sequential temozolomide (TMZ): A case series
    Swami, Umang
    Monga, Varun
    Zakharia, Yousef
    Milhem, Mohammed M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [38] Clinical determinants of long-term survival in metastatic uveal melanoma
    Koch, Elias A. T.
    Petzold, Anne
    Wessely, Anja
    Dippel, Edgar
    Erdmann, Michael
    Heinzerling, Lucie
    Hohberger, Bettina
    Knorr, Harald
    Leiter, Ulrike
    Meier, Friedegund
    Mohr, Peter
    Rahimi, Farnaz
    Schell, Beatrice
    Schlaak, Max
    Terheyden, Patrick
    Schuler-Thurner, Beatrice
    Ugurel, Selma
    Utikal, Jochen
    Vera, Julio
    Weichenthal, Michael
    Ziller, Fabian
    Berking, Carola
    Heppt, Markus, V
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1467 - 1477
  • [39] Clinical determinants of long-term survival in metastatic uveal melanoma
    Elias A. T. Koch
    Anne Petzold
    Anja Wessely
    Edgar Dippel
    Michael Erdmann
    Lucie Heinzerling
    Bettina Hohberger
    Harald Knorr
    Ulrike Leiter
    Friedegund Meier
    Peter Mohr
    Farnaz Rahimi
    Beatrice Schell
    Max Schlaak
    Patrick Terheyden
    Beatrice Schuler-Thurner
    Selma Ugurel
    Jochen Utikal
    Julio Vera
    Michael Weichenthal
    Fabian Ziller
    Carola Berking
    Markus V. Heppt
    Cancer Immunology, Immunotherapy, 2022, 71 : 1467 - 1477
  • [40] Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma
    Gibney, Geoffrey T.
    Atkins, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1873 - U27